ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Heron Begins Phase 2 Clinical Study of Cinvanti for COVID-19
July 27, 2020Heron Therapeutics announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating CINVANTI (aprepitant) injectable emulsion in early hospitalized patients with Coronavirus Disease 2019 (COVID-19). -
Heron Announces FDA Approval of sNDA to Expand CINVANTI® Label for IV Push
February 28, 2019Heron Therapeutics announced the U.S. Food and Drug Administration (FDA) has approved Heron's supplemental New Drug Application (sNDA) for CINVANTI (aprepitant) injectable emulsion... -
Heron takes on Merck's Emend with FDA win for antinausea drug Cinvanti
November 13, 2017Merck’s drug for chemo-induced nausea and vomiting has some new competition.
Pharma Sources Insight January 2025
